Josh Brumm
2023
In 2023, Josh Brumm earned a total compensation of $6M as Former President and Chief Executive Officer at Dyne Therapeutics, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $460,138 |
|---|---|
| Option Awards | $965,225 |
| Salary | $643,550 |
| Stock Awards | $3,904,582 |
| Other | $996 |
| Total | $5,974,491 |
Brumm received $3.9M in stock awards, accounting for 65% of the total pay in 2023.
Brumm also received $460.1K in non-equity incentive plan, $965.2K in option awards, $643.6K in salary and $996 in other compensation.
Rankings
In 2023, Josh Brumm's compensation ranked 77th out of 2,978 executives tracked by ExecPay. In other words, Brumm earned more than 97.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 77 out of 2,978 | 97th |
Division Manufacturing | 39 out of 1,637 | 98th |
Major group Chemicals And Allied Products | 29 out of 906 | 97th |
Industry group Drugs | 28 out of 869 | 97th |
Industry Pharmaceutical Preparations | 19 out of 627 | 97th |
Source: SEC filing on April 5, 2024.
Brumm's colleagues
We found two more compensation records of executives who worked with Josh Brumm at Dyne Therapeutics in 2023.